CELLULAR BIOMEDICINE GROUP, INC. Increase (Decrease) in Prepaid Expense and Other Assets
CELLULAR BIOMEDICINE GROUP, INC. reported Increase (Decrease) in Prepaid Expense and Other Assets of -$831.69 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2020-02-28
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in prepaid expense and other assets for fiscal 2019 was -$831.69K.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in prepaid expense and other assets for fiscal 2018 was -$68.44K, a 108.42% decline from fiscal 2017.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in prepaid expense and other assets for fiscal 2017 was $812.67K, a 21.37% increase from fiscal 2016.
- CELLULAR BIOMEDICINE GROUP, INC. increase (decrease) in prepaid expense and other assets for fiscal 2016 was $669.60K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|
| 2019-12-31 | -$831.69K 10-K · filed 2020-02-28 |
| 2018-12-31 | -$68.44K 10-K · filed 2020-02-28 |
| 2017-12-31 | $812.67K 10-K · filed 2020-02-28 |
| 2016-12-31 | $669.60K 10-K · filed 2019-02-19 |
| 2015-12-31 | -$181.68K 10-K · filed 2018-03-05 |
| 2014-12-31 | $494.06K 10-K · filed 2017-03-13 |
| 2013-12-31 | $38.79K 10-K · filed 2016-03-14 |